Table 5.
Relations between response to levodopa treatment and other variables.
| Variables | Response to Levodopa | p Value | ||
|---|---|---|---|---|
| NO | YES | |||
| Diagnosis | Probable | 97 (74%) | 7 (87.5%) | p > 0.05 |
| Possible | 34 (25.9%) | 1 (12.5%) | ||
| SPECT qualitative assessment | Pathological | 104 (79.4%) | 5 (62.5%) | p > 0.05 |
| Non-pathological | 27 (20.6%) | 3 (37.5%) | ||
| SPECT quantitative assessment | Global S/O | 1.345 (0.175) | 1.407 (0.174) | p > 0.05 |
| Right S/O | 1.352 (0.180) | 1.424 (0.188) | p > 0.05 | |
| Left S/O | 1.337 (0.175) | 1.390 (0.162) | p > 0.05 | |
| MSA type | MSA-C | 49 (37.4%) | 3 (37.5%) | p > 0.05 |
| MSA-P | 82 (62.6%) | 5 (62.5%) | ||
S/O: Striatum/Occipital; MSA: Multiple System Atrophy; MSA-P: Multiple System Atrophy Parkinsonian Type; MSA-C: Multiple System Atrophy Cerebellar Type.